Live from the NIH registry
Studies recruiting near Ocala right now
Top 25 of 124 recruiting studies, sorted by proximity — each links to its official registry page
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Non-small Cell Lung Cancer, Melanoma
Phase 1
Interventional 174 participants sought
Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
K2 Medical Research — Lady Lake, Florida (22.7 mi)
· Sponsor: Lantheus Biosciences Ltd.
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Phase 3
Interventional 600 participants sought
Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: Summit Therapeutics
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Urinary Tract Infections
Phase 2
Interventional 318 participants sought
Research Site 153 — Ocala, Florida (0.9 mi)
· Sponsor: Locus Biosciences
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — Wildwood, Florida (22.6 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Wildwood Clinical Research / Florida Retina Institute — Wildwood, Florida (22.6 mi)
· Sponsor: EyeBiotech Ltd.
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Melanoma, Non-small Cell Lung Cancer
Phase 2
Interventional 178 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Ocala Cardiovascular Research — Ocala, Florida (0.9 mi)
· Sponsor: Amgen
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Advanced Urology Institute — Oxford, Florida (18.6 mi)
· Sponsor: CG Oncology, Inc.
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 150 participants sought
Ocala Oncology Center /ID# 273697 — Ocala, Florida (0.9 mi)
· Sponsor: AbbVie
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — The Villages, Florida (20.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Charter Research - The Villages — The Villages, Florida (20.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 630 participants sought
Local Institution - 0680 — Ocala, Florida (0.9 mi)
· Sponsor: Mirati Therapeutics Inc.
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
Renstar Medical Research ( Site 1012) — Ocala, Florida (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis, Atopic Dermatitis Eczema
Phase 2
Interventional 405 participants sought
Inmagene Site 19 — Ocala, Florida (0.9 mi)
· Sponsor: Inmagene LLC
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Pfizer
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Obesity or Overweight
Phase 3
Interventional 300 participants sought
Charter Research - The Villages — The Villages, Florida (20.4 mi)
· Sponsor: Amgen
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
Ocala Oncology Florida Cancer Affiliates - Main /ID# 234228 — Ocala, Florida (0.9 mi)
· Sponsor: AbbVie
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Ocala Oncology Center PL - 1102 — Ocala, Florida (0.9 mi)
· Sponsor: OncoC4, Inc.
Pan Tumor Rollover Study
Cancer
Phase 2
Interventional 1,500 participants sought
Florida Cancer Affiliates — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.0 mi)
· Sponsor: Janssen Research & Development, LLC
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2
Interventional 400 participants sought
Advanced Urology Institute — Ocala, Florida (0.9 mi)
· Sponsor: Dendreon